Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.2951
$0.00190.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.08M | 3.86M | 2.76M | 2.55M | 2.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.70M | 7.20M | 5.75M | 5.73M | 5.89M |
| Operating Income | -7.70M | -7.20M | -5.75M | -5.73M | -5.89M |
| Income Before Tax | -9.14M | -9.19M | -7.20M | -7.35M | -6.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.14 | -9.19 | -7.20 | -7.35 | -6.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.14M | -9.19M | -7.20M | -7.35M | -6.59M |
| EBIT | -7.70M | -7.20M | -5.75M | -5.73M | -5.89M |
| EBITDA | -7.69M | -7.20M | -5.74M | -5.73M | -5.89M |
| EPS Basic | -3.71 | -4.20 | -3.53 | -3.79 | -3.53 |
| Normalized Basic EPS | -2.11 | -2.43 | -2.19 | -2.20 | -2.06 |
| EPS Diluted | -3.79 | -4.20 | -3.53 | -3.79 | -3.53 |
| Normalized Diluted EPS | -2.11 | -2.43 | -2.19 | -2.20 | -2.06 |
| Average Basic Shares Outstanding | 11.48M | 8.57M | 8.16M | 7.83M | 7.46M |
| Average Diluted Shares Outstanding | 11.48M | 8.57M | 8.16M | 7.83M | 7.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |